N
Nora D. Volkow
Researcher at National Institute on Drug Abuse
Publications - 1038
Citations - 121498
Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.
Papers
More filters
Journal ArticleDOI
Decreased dopamine transporters with age in healthy human subjects
Nora D. Volkow,Joanna S. Fowler,Gene-Jack Wang,J. Logan,D. Schlyer,R. MacGregor,Robert Hitzemann,A. P. Wolf +7 more
TL;DR: The results document an age‐related decline in dopamine transporters in healthy individuals.
Journal ArticleDOI
Opioid use disorder.
John Strang,John Strang,Nora D. Volkow,Louisa Degenhardt,Matthew Hickman,Kimberly Johnson,George F. Koob,Brandon D.L. Marshall,Mark W. Tyndall,Sharon L. Walsh +9 more
TL;DR: The risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment, are discussed, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups.
Journal ArticleDOI
Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation
Gene-Jack Wang,Nora D. Volkow,Frank Telang,Millard Jayne,Yeming Ma,Kith Pradhan,Wei Zhu,Christopher Wong,Panayotis K. Thanos,Allan Geliebter,Anat Biegon,Joanna S. Fowler +11 more
TL;DR: A mechanism by which cognitive inhibition decreases the desire for food and implicates lower ability to suppress hunger in women as a contributing factor to gender differences in obesity is suggested.
Journal ArticleDOI
Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects
Gwenn S. Smith,Ralf Schloesser,Jonathan D. Brodie,Stephen L. Dewey,Jean Logan,Stephen A. Vitkun,Philip Simkowitz,Arlene Hurley,Thomas B. Cooper,Nora D. Volkow,Robert Cancro +10 more
TL;DR: In vivo evidence is provided for the ability of ketamine to increase striatal dopamine concentrations, consistent with the role of the NMDA receptor in modulating dopamine function.
Journal ArticleDOI
Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment
TL;DR: Suggestions should be considered for improving current noncancer pain management in primary health care settings that could decrease diversion, abuse, and overdose of opioid medications.